Compare BEPC & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BEPC | TFX |
|---|---|---|
| Founded | 2019 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.8B |
| IPO Year | 2019 | 1994 |
| Metric | BEPC | TFX |
|---|---|---|
| Price | $28.56 | $122.93 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 8 |
| Target Price | $39.75 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 1.6M | 624.7K |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.46% | 1.02% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.08 |
| Revenue | N/A | ★ $1,992,713,000.00 |
| Revenue This Year | $78.11 | $15.97 |
| Revenue Next Year | N/A | $5.15 |
| P/E Ratio | ★ N/A | $57.74 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $28.09 | $100.18 |
| 52 Week High | $45.18 | $145.00 |
| Indicator | BEPC | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 30.05 | 32.35 |
| Support Level | N/A | $119.69 |
| Resistance Level | $33.08 | $123.47 |
| Average True Range (ATR) | 0.81 | 3.77 |
| MACD | -0.10 | -1.19 |
| Stochastic Oscillator | 9.72 | 21.01 |
Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia, and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners LP and Brookfield Renewable Corp.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.